Susan L. Uprichard

Robust hepatitis C virus infection <i>in vitro</i>

Jin Zhong, Pablo Gastaminza, Guofeng Cheng et al. · Proceedings of the National Academy of Sciences · 2005 · 1.7K citations

Life Sciences, Infectious Diseases, Microbiology +15

Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

Bruno Sáinz, Naina Barretto, Danyelle N. Martin et al. · Nature Medicine · 2012 · 436 citations

Life Sciences, Biochemistry, Infectious Diseases +12

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

Jérémie Guedj, Harel Dahari, Libin Rong et al. · Proceedings of the National Academy of Sciences · 2013 · 342 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Christopher Koh, Laëtitia Canini, Harel Dahari et al. · The Lancet Infectious Diseases · 2015 · 263 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Identification of transferrin receptor 1 as a hepatitis C virus entry factor

Danyelle N. Martin, Susan L. Uprichard · Proceedings of the National Academy of Sciences · 2013 · 212 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16